Clinical trial · Observational
The Gut Immune System During Immune Checkpoint Inhibitor Therapy
Deep Phenotyping of the Gut Immune System During Immune Checkpoint Inhibitor Therapy - DEFENCE
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This exploratory study aims to gain insight in gut immune system phenotypes before and after immunotherapy. After informed consent is obtained, sigmoidoscopies at baseline and during treatment with immunotherapy will be performed, During the endoscopies, biopsies from the sigmoid and rectum will be obtained. Subsequent immune cell analyses in these biopsies will be performed. Parallel to the sigmoidoscopies, venous blood samples will be obtained to monitor inflammatory markers.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| sigmoidoscopies and and venous blood sampling | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Palliative treatment with immunotherapy
- interventionNames
- Procedure: sigmoidoscopies and and venous blood sampling
Primary outcomes (1)
- measure
- CD8+ T cell count in the gut mucosa
- timeFrame
- 8 weeks
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Indication for treatment with anti PD1/PDL1 based immunotherapy * Written informed consent * Evaluable according to iRECIST v1.1 Exclusion Criteria: * Concomitant, chronic or infectious illness in the past 6 months causing moderate to severe colitis * Use of a medication in the past 6 months with an elevated risk of moderate to severe colitis * Gastrointestinal resection or enterostomy * Abdominal radiotherapy in the past 6 months
References
Publications (0)
Data not yet available